These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 17301639

  • 1. Adverse clinical events in patients treated with sirolimus-eluting stents: the impact of Type D personality.
    Pedersen SS, Denollet J, Ong AT, Sonnenschein K, Erdman RA, Serruys PW, van Domburg RT.
    Eur J Cardiovasc Prev Rehabil; 2007 Feb; 14(1):135-40. PubMed ID: 17301639
    [Abstract] [Full Text] [Related]

  • 2. Type D personality predicts death or myocardial infarction after bare metal stent or sirolimus-eluting stent implantation: a Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry substudy.
    Pedersen SS, Lemos PA, van Vooren PR, Liu TK, Daemen J, Erdman RA, Smits PC, Serruys PW, van Domburg RT.
    J Am Coll Cardiol; 2004 Sep 01; 44(5):997-1001. PubMed ID: 15337209
    [Abstract] [Full Text] [Related]

  • 3. Type-D personality predicts chronic anxiety following percutaneous coronary intervention in the drug-eluting stent era.
    Spindler H, Pedersen SS, Serruys PW, Erdman RA, van Domburg RT.
    J Affect Disord; 2007 Apr 01; 99(1-3):173-9. PubMed ID: 17049996
    [Abstract] [Full Text] [Related]

  • 4. Type-D personality exerts a stable, adverse effect on vital exhaustion in PCI patients treated with paclitaxel-eluting stents.
    Pedersen SS, Daemen J, van de Sande M, Sonnenschein K, Serruys PW, Erdman RA, van Domburg RT.
    J Psychosom Res; 2007 Apr 01; 62(4):447-53. PubMed ID: 17383496
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Sirolimus-eluting stents remain superior to bare-metal stents at two years: medium-term results from the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry.
    Ong AT, van Domburg RT, Aoki J, Sonnenschein K, Lemos PA, Serruys PW.
    J Am Coll Cardiol; 2006 Apr 04; 47(7):1356-60. PubMed ID: 16580521
    [Abstract] [Full Text] [Related]

  • 7. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
    Stone GW, Midei M, Newman W, Sanz M, Hermiller JB, Williams J, Farhat N, Caputo R, Xenopoulos N, Applegate R, Gordon P, White RM, Sudhir K, Cutlip DE, Petersen JL, SPIRIT III Investigators.
    Circulation; 2009 Feb 10; 119(5):680-6. PubMed ID: 19171853
    [Abstract] [Full Text] [Related]

  • 8. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry.
    Lemos PA, Serruys PW, van Domburg RT, Saia F, Arampatzis CA, Hoye A, Degertekin M, Tanabe K, Daemen J, Liu TK, McFadden E, Sianos G, Hofma SH, Smits PC, van der Giessen WJ, de Feyter PJ.
    Circulation; 2004 Jan 20; 109(2):190-5. PubMed ID: 14691037
    [Abstract] [Full Text] [Related]

  • 9. Long-term (>3 Years) outcome and predictors of clinical events after insertion of sirolimus-eluting stent in one or more native coronary arteries (from the Israeli arm of the e-Cypher registry).
    Planer D, Beyar R, Almagor Y, Banai S, Guetta V, Miller H, Kornowski R, Brandes S, Krakover R, Solomon M, Lotan C.
    Am J Cardiol; 2008 Apr 01; 101(7):953-9. PubMed ID: 18359314
    [Abstract] [Full Text] [Related]

  • 10. Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison.
    Brugaletta S, Burzotta F, Trani C, Todaro D, Talarico G, Porto I, Leone AM, Niccoli G, Mazzari MA, Mongiardo R, Schiavoni G, Crea F.
    Minerva Cardioangiol; 2008 Feb 01; 56(1):35-42. PubMed ID: 18432167
    [Abstract] [Full Text] [Related]

  • 11. Usefulness of type D personality in predicting five-year cardiac events above and beyond concurrent symptoms of stress in patients with coronary heart disease.
    Denollet J, Pedersen SS, Vrints CJ, Conraads VM.
    Am J Cardiol; 2006 Apr 01; 97(7):970-3. PubMed ID: 16563897
    [Abstract] [Full Text] [Related]

  • 12. Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients: the EVASTENT Matched-Cohort Registry.
    Machecourt J, Danchin N, Lablanche JM, Fauvel JM, Bonnet JL, Marliere S, Foote A, Quesada JL, Eltchaninoff H, Vanzetto G, EVASTENT Investigators.
    J Am Coll Cardiol; 2007 Aug 07; 50(6):501-8. PubMed ID: 17678732
    [Abstract] [Full Text] [Related]

  • 13. Comparative clinical outcomes of paclitaxel- and sirolimus-eluting stents: results from a large prospective multicenter registry--STENT Group.
    Simonton CA, Brodie B, Cheek B, Krainin F, Metzger C, Hermiller J, Juk S, Duffy P, Humphrey A, Nussbaum M, Laurent S, STENT Group.
    J Am Coll Cardiol; 2007 Sep 25; 50(13):1214-22. PubMed ID: 17888837
    [Abstract] [Full Text] [Related]

  • 14. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents.
    Whan Lee C, Kim SH, Suh J, Park DW, Lee SH, Kim YH, Hong MK, Kim JJ, Park SW, Park SJ.
    Catheter Cardiovasc Interv; 2008 Apr 01; 71(5):594-8. PubMed ID: 18311841
    [Abstract] [Full Text] [Related]

  • 15. Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent era.
    Pucelikova T, Mehran R, Kirtane AJ, Kim YH, Fahy M, Weisz G, Lansky AJ, Moussa I, Gray WA, Collins MB, Kodali SK, Stone GW, Moses JW, Leon MB, Dangas G.
    Am J Cardiol; 2008 Jan 01; 101(1):63-8. PubMed ID: 18157967
    [Abstract] [Full Text] [Related]

  • 16. Outcome in the elderly undergoing percutaneous coronary intervention with sirolimus-eluting stents: results from the prospective multicenter German Cypher Stent Registry.
    Wiemer M, Langer C, Kottmann T, Horstkotte D, Hamm C, Pfannebecker TH, Tebbe U, Schneider S, Senges J.
    Am Heart J; 2007 Oct 01; 154(4):682-7. PubMed ID: 17892991
    [Abstract] [Full Text] [Related]

  • 17. Drug-eluting stents in the elderly: long-term (> one year) clinical outcomes of octogenarians in the DESIRE (Drug-Eluting Stents In the REal world) registry.
    Costa JR, Sousa A, Moreira AC, Costa RA, Maldonado G, Cano MN, Egito ET, Romano ER, Barbosa M, Pavanello R, Jardim C, Cury A, Berwanger O, Sousa JE.
    J Invasive Cardiol; 2008 Aug 01; 20(8):404-10. PubMed ID: 18688065
    [Abstract] [Full Text] [Related]

  • 18. Three-year clinical follow-up of the unrestricted use of sirolimus-eluting stents as part of the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry.
    Daemen J, Ong AT, Stefanini GG, Tsuchida K, Spindler H, Sianos G, de Jaegere PP, van Domburg RT, Serruys PW.
    Am J Cardiol; 2006 Oct 01; 98(7):895-901. PubMed ID: 16996869
    [Abstract] [Full Text] [Related]

  • 19. Type D personality and diabetes predict the onset of depressive symptoms in patients after percutaneous coronary intervention.
    Pedersen SS, Ong AT, Sonnenschein K, Serruys PW, Erdman RA, van Domburg RT.
    Am Heart J; 2006 Feb 01; 151(2):367.e1-367.e6. PubMed ID: 16442900
    [Abstract] [Full Text] [Related]

  • 20. Four-year clinical follow-up of the rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital registry.
    Daemen J, Kukreja N, van Twisk PH, Onuma Y, de Jaegere PP, van Domburg R, Serruys PW.
    Am J Cardiol; 2008 Apr 15; 101(8):1105-11. PubMed ID: 18394442
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.